BR9707566B1 - derivados de feniletanolamino tetralincarboxamida 3,4-dissubstituidos. - Google Patents

derivados de feniletanolamino tetralincarboxamida 3,4-dissubstituidos.

Info

Publication number: BR9707566B1
Authority: BR; Brazil
Prior art keywords: carbon atom; amino; disubstituted; configuration; tetralincarboxamide
Prior art date: 1996-02-19

Application number

BRPI9707566-3A

Other languages

English (en)

Other versions

BR9707566A (pt

Inventor

Makio Kitazawa

Kosuke Okazaki

Tetsuro Tamai

Masaru Saito

Nobuyuki Tanaka

Hiroaki Kobayashi

Ken Kikuchi

Hideyuki Muranaka

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-02-19

Filing date

1997-02-18

Publication date

2010-08-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13386565&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9707566(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-02-18 Application filed filed Critical

1999-07-27 Publication of BR9707566A publication Critical patent/BR9707566A/pt

2010-08-10 Publication of BR9707566B1 publication Critical patent/BR9707566B1/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pulmonology (AREA)
Pregnancy & Childbirth (AREA)
Gynecology & Obstetrics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Detergent Compositions (AREA)
Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)

BRPI9707566-3A 1996-02-19 1997-02-18 derivados de feniletanolamino tetralincarboxamida 3,4-dissubstituidos. BR9707566B1 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP6888596		1996-02-19
PCT/JP1997/000424 WO1997030023A1 (en)	1996-02-19	1997-02-18	3,4-disubstituted phenylethanolaminotetralincarboxamide derivatives

Publications (2)

Publication Number	Publication Date
BR9707566A BR9707566A (pt)	1999-07-27
BR9707566B1 true BR9707566B1 (pt)	2010-08-10

Family

ID=13386565

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI9707566-3A BR9707566B1 (pt)	1996-02-19	1997-02-18	derivados de feniletanolamino tetralincarboxamida 3,4-dissubstituidos.

Country Status (24)

Country	Link
US (1)	US6133266A (pt)
EP (1)	EP0882704B1 (pt)
JP (1)	JP3892045B2 (pt)
KR (1)	KR100491633B1 (pt)
CN (1)	CN1100032C (pt)
AT (1)	ATE225767T1 (pt)
AU (1)	AU725042B2 (pt)
BR (1)	BR9707566B1 (pt)
CA (1)	CA2245490C (pt)
CZ (1)	CZ293974B6 (pt)
DE (1)	DE69716242T2 (pt)
DK (1)	DK0882704T3 (pt)
EA (1)	EA002143B1 (pt)
ES (1)	ES2184989T3 (pt)
HU (1)	HU229400B1 (pt)
ID (1)	ID16091A (pt)
MY (1)	MY123853A (pt)
NO (1)	NO323095B1 (pt)
NZ (1)	NZ331445A (pt)
PL (1)	PL186411B1 (pt)
PT (1)	PT882704E (pt)
SG (1)	SG72727A1 (pt)
TW (1)	TW375604B (pt)
WO (1)	WO1997030023A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU8562098A (en) *	1997-08-19	1999-03-08	Kissei Pharmaceutical Co. Ltd.	Phenylethanolaminotetralin derivatives and bronchodilators
ZA994264B (en)	1998-07-01	2000-01-25	Warner Lambert Co	Stereoisomers with high affinity for adrenergic receptors.
GB9913083D0 (en)	1999-06-04	1999-08-04	Novartis Ag	Organic compounds
US7232837B2 (en)	1999-06-29	2007-06-19	Mcneil-Ppc, Inc.	Stereoisomers with high affinity for adrenergic receptors
FR2809725B1 (fr)	2000-06-06	2004-05-07	Sanofi Synthelabo	Propanolaminotetralines, leur preparation et compositions pharmaceutiques en contenant
GB0029562D0 (en)	2000-12-04	2001-01-17	Novartis Ag	Organic compounds
AU2004206161B2 (en) *	2003-01-22	2008-07-03	Kissei Pharmaceutical Co., Ltd.	Preventive or remedy for intrauterine late embryonic development or pregnancy toxemia
WO2006054513A1 (ja) *	2004-11-19	2006-05-26	Kissei Pharmaceutical Co., Ltd.	神経因性疼痛の予防又は治療剤
WO2006054514A1 (ja) *	2004-11-19	2006-05-26	Kissei Pharmaceutical Co., Ltd.	神経因性疼痛の予防又は治療用医薬組成物
EP2098511A1 (en)	2008-03-07	2009-09-09	Solvias AG	Process for preparing compounds containing a hydronaphtalene structure with an unsymmetrically substituted benzene ring
KR20140015150A (ko) *	2009-11-18	2014-02-06	메디시노바, 인크.	급성 악화성 천식의 치료 및 이로부터 고통받는 환자의 입원 가능성의 감소
WO2011112499A1 (en) *	2010-03-08	2011-09-15	Medicinova, Inc.	Compositions, methods, and devices for the treatment of dysmenorrhea
CN102869645A (zh) *	2010-04-08	2013-01-09	美迪诺亚公司	用于治疗肠易激综合征的方法和组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9107827D0 (en) *	1991-04-12	1991-05-29	Fujisawa Pharmaceutical Co	New ethanolamine derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
IL104567A (en) *	1992-02-03	1997-03-18	Fujisawa Pharmaceutical Co	Ethanolamine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
WO1993018007A1 (fr) *	1992-03-13	1993-09-16	Tokyo Tanabe Company Limited	Nouveau derive de carbostyrile

1997
- 1997-02-17 SG SG1997000355A patent/SG72727A1/en unknown
- 1997-02-17 TW TW086102182A patent/TW375604B/zh not_active IP Right Cessation
- 1997-02-18 JP JP52920097A patent/JP3892045B2/ja not_active Expired - Lifetime
- 1997-02-18 CN CN97193866A patent/CN1100032C/zh not_active Expired - Lifetime
- 1997-02-18 CA CA002245490A patent/CA2245490C/en not_active Expired - Lifetime
- 1997-02-18 BR BRPI9707566-3A patent/BR9707566B1/pt not_active IP Right Cessation
- 1997-02-18 PL PL97328530A patent/PL186411B1/pl unknown
- 1997-02-18 MY MYPI97000600A patent/MY123853A/en unknown
- 1997-02-18 DK DK97902714T patent/DK0882704T3/da active
- 1997-02-18 DE DE69716242T patent/DE69716242T2/de not_active Expired - Lifetime
- 1997-02-18 PT PT97902714T patent/PT882704E/pt unknown
- 1997-02-18 CZ CZ19982523A patent/CZ293974B6/cs not_active IP Right Cessation
- 1997-02-18 HU HU9900621A patent/HU229400B1/hu unknown
- 1997-02-18 WO PCT/JP1997/000424 patent/WO1997030023A1/ja not_active Ceased
- 1997-02-18 AT AT97902714T patent/ATE225767T1/de active
- 1997-02-18 NZ NZ331445A patent/NZ331445A/xx not_active IP Right Cessation
- 1997-02-18 EA EA199800644A patent/EA002143B1/ru not_active IP Right Cessation
- 1997-02-18 US US09/125,429 patent/US6133266A/en not_active Expired - Lifetime
- 1997-02-18 ES ES97902714T patent/ES2184989T3/es not_active Expired - Lifetime
- 1997-02-18 KR KR10-1998-0706378A patent/KR100491633B1/ko not_active Expired - Lifetime
- 1997-02-18 AU AU20014/97A patent/AU725042B2/en not_active Expired
- 1997-02-18 EP EP97902714A patent/EP0882704B1/en not_active Expired - Lifetime
- 1997-02-19 ID IDP970478A patent/ID16091A/id unknown
1998
- 1998-08-18 NO NO19983777A patent/NO323095B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
CN1216526A (zh)	1999-05-12
CN1100032C (zh)	2003-01-29
AU2001497A (en)	1997-09-02
CZ293974B6 (cs)	2004-09-15
NZ331445A (en)	2000-01-28
EP0882704B1 (en)	2002-10-09
US6133266A (en)	2000-10-17
CA2245490C (en)	2005-10-25
HUP9900621A3 (en)	1999-11-29
DK0882704T3 (da)	2003-02-17
JP3892045B2 (ja)	2007-03-14
NO983777L (no)	1998-10-19
PL186411B1 (pl)	2004-01-30
EA002143B1 (ru)	2001-12-24
ES2184989T3 (es)	2003-04-16
PL328530A1 (en)	1999-02-01
AU725042B2 (en)	2000-10-05
WO1997030023A1 (en)	1997-08-21
EP0882704A4 (en)	2000-06-14
CZ252398A3 (cs)	1998-12-16
SG72727A1 (en)	2000-05-23
NO983777D0 (no)	1998-08-18
MY123853A (en)	2006-06-30
NO323095B1 (no)	2007-01-02
KR100491633B1 (ko)	2005-09-09
CA2245490A1 (en)	1997-08-21
EA199800644A1 (ru)	1999-02-25
HUP9900621A2 (hu)	1999-08-30
DE69716242D1 (de)	2002-11-14
DE69716242T2 (de)	2003-07-24
PT882704E (pt)	2003-02-28
TW375604B (en)	1999-12-01
BR9707566A (pt)	1999-07-27
KR19990082638A (ko)	1999-11-25
HU229400B1 (en)	2013-12-30
ID16091A (id)	1997-09-04
EP0882704A1 (en)	1998-12-09
ATE225767T1 (de)	2002-10-15

Publication	Publication Date	Title
PT882704E (pt)	2003-02-28	Derivados de feniletanolaminotetralinocarboxamida 3,4-dissubstituidos
ES2141137T3 (es)	2000-03-16	Agentes terapeuticos para la enfermedad de parkinson.
IE861820L (en)	1987-01-10	2-hydroxy-2-phenylethylaminotetralines
PL283642A1 (en)	1991-02-11	Method of obtaining novel heterocyclic benzocondensated derivatives containing nitrogen atom
MX9300552A (es)	1993-09-01	Derivados de etanolamina
EP0640601A4 (en)	1994-03-07	Benzamide derivative.
ES2180034T3 (es)	2003-02-01	Derivados de feniletanolaminotetralincarboxilato disustituidos en las posiciones 3 y 4.
NO913023L (no)	1991-08-02	Nye bicykliske aminosubstituerte forbindelser
BR9708642A (pt)	1999-08-03	Derivados de feniletanolaminotetralincarboxamida
IL83216A (en)	1991-07-18	1((5-(10->9)abeo-6-methylergolin-8beta-yl)methyl)-imidazolidine-(and hexahydropyrimidine)-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them
KR920008034A (ko)	1992-05-27	항고혈압 작용 및 혈관 확장 활성있는 벤조피란 유도체, 그의 제법 및 그의 치료적 용도
CA2251090A1 (en)	1997-10-23	Phenylethanolaminotetralincarboxamide derivatives
EP0919233B8 (en)	2003-08-13	Therapeutic agent for kidney diseases
EP0420464A3 (en)	1991-07-17	3-isoxazolone derivatives, their preparation and their therapeutic uses
ECSP972209A (es)	1999-01-19	Nuevos compuestos, procedimientos para su preparacion, composiciones, farmaceuticas y su uso en terapia

Legal Events

Date	Code	Title	Description
2007-01-30	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2007-01-30	B15K	Others concerning applications: alteration of classification	Free format text: ALTERADA DE INT.CL.8: C07C 235/06, C07C 235/86 ,C07D 295/ 185, A61K 31/165, A61K 31/402, A61K 31/445, A61K 31/5375, A61P 9/00, A61P 9/06, A61P 11/00, A61P 11/08, A61P 13/00, A61P 13/04, A61P 15/00, A61P 15/06 Ipc: C07C 235/06, C07C 235/86, C07D 295/185, A61K 31/16
2007-10-09	B09B	Patent application refused [chapter 9.2 patent gazette]	Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE ESTE NAO ATENDE AO REQUISITO DE ATIVIDADE INVENTIVA ( ARTIGO 8O COMBINADO COM O ARTIGO 13 DA LEI 9279 DE 1996.
2008-03-04	B12B	Appeal against refusal [chapter 12.2 patent gazette]
2010-08-10	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/08/2010, OBSERVADAS AS CONDICOES LEGAIS.
2013-04-24	B24B	Patent annual fee: requirement for complementing annual fee	Free format text: COMPLEMENTAR A RETRIBUICAO DA 17A ANUIDADE DE ACORDO COM A TABELA VIGENTE, REFERENTE A GUIA DE RECOLHIMENTO 921301839123.
2013-10-08	B22O	Other matters related to patents and certificates of addition of invention: legal action concerning patent	Free format text: INPI-52400.061555/2013 ORIGEM: JUIZO DA 013A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO 0132366-77.2013.4.02.5101 ACAO DE NULIDADE DAS PATENTES SUBMETIDAS AO MAILBOX (ART. 229, PARAGRAFO UNICO DA LPI); ALTERNATIVAMENTE, A DECRETACAO DA NULIDADE PARCIAL PARA CORRECAO DO PRAZO DE VIGENCIA; SUBSIDIARIAMENTE, CASO SE ENTENDA NAO SER O CASO DE NULIDADE, A CORRECAO DO ATO ADMINISTRATIVO PARA ADEQUACAO DA VIGENCIA DAS PATENTES. AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU: CORIXA CORPORATION,DAIICHI PHARMACEUTICAL CO., LTD, EURO-CETIQUE S.A, IPSEN PHARMA S.AS. , KISSEI PHAMACEUTICAL CO., LTD.
2013-12-17	B21B	Extinction acc. art. 78, item ii - on waiver by the patentee, without prejudice to the rights of third parties	Free format text: SOLICITADA ATRAVES DA PETICAO 20130090955 (RJ), DE 02/12/2013
2013-12-17	B24D	Patent annual fee: restoration after fee payment
2014-06-24	B19A	Notification of judicial decision: notification of judicial decision	Free format text: INPI- 52400.061555/2013 SECAO JUDICIARIA DO ESTADO DO RIO DE JANEIRO 13A VARA FEDERAL DO RIO DE JANEIRO ACAO ORDINARIA PROCESSO NO 0132366-77.2013.4.02.5101 AUTOR: INPI REUS:CORIXA CORPORATION, DAIICHI PHARMACEUTICAL CO., LTD, EURO-CETIQUE S.A, IPSEN PHARMA S.A.S., KISSEI PHARMACEUTICAL CO. LTD. DECISAO: I DA PERDA DO OBJETO QUANTO AS PATENTES PI9612997-2, PI9608040-0, PI9506779-5, PI9508687-0 E PI9707566-3 PELA EXTINCAO DO PRESENTE FEITO EM RELACAO A ESTAS PATENTES, COM BASE NO ART. 267, INCISO VI, DO CPC, PELA PERDA DO OBJETO. II DA PATENTE PI9611455-0, DE TITULARIDADE DA EMPRESA CORIXA CORPORATION, JULGO PROCEDENTE A PRETENSAO DO INPI PARA DETERMINAR A REDUCAO DO PRAZO DE VIGEN